Ohio State Conducts 1st Gene Therapy Clinical Trial for Huntington's Disease
June 25, 2020
June 25, 2020
NEW YORK, June 25 -- The Huntington's Disease Society of America issued the following news:
In a worldwide first, surgeons at The Ohio State University Wexner Medical Center have treated two patients with Huntington's disease using a novel gene therapy treatment as part of a multi-center, double-blind randomized clinical trial.
Huntington's disease is an inherited genetic disorder that results in progressive physical and cognitive deterioration, ultimately leading to de . . .
In a worldwide first, surgeons at The Ohio State University Wexner Medical Center have treated two patients with Huntington's disease using a novel gene therapy treatment as part of a multi-center, double-blind randomized clinical trial.
Huntington's disease is an inherited genetic disorder that results in progressive physical and cognitive deterioration, ultimately leading to de . . .